Private Equity 3 Days

Last updated: May 31, 2026, 11:31 AM ET

Fundraising & Capital Deployment Actis secured $2.5bn at the first close of its $6bn flagship energy fund, signaling strong investor appetite for sustainable infrastructure despite a broader slowdown in private‑equity fundraising. Across Europe, EQT appointed Nicholas Macksey and Hari Gopalakrishnan to co‑lead its Private Capital Asia platform, tasking the duo with deploying a record $15.6bn regional fund that will target growth‑stage tech and consumer assets. Meanwhile, BCI launched a Capital Solutions Group to provide bridge financing to buyout firms facing a “liquidity drought” as exits remain scarce, reflecting the growing need for non‑traditional capital sources in a market where deal‑making cycles have lengthened.

Strategic Exits & Restructurings Ares pushed ahead with an Eagle Football restructuring as Met Life evaluated creditor terms, highlighting the pressure on multi‑club ownership models to refinance debt amid tighter credit conditions. In the UK, MidOcean announced the sale of Zonda to CoStar Group, a move that will integrate Zonda’s real‑estate data platform into CoStar’s expanding analytics suite and generate a multi‑hundred‑million‑dollar return for Mid Ocean’s investors. Across the Atlantic, Bain Capital prepared to sell Estia Health to Stonepeak, a transaction that will hand the Australian aged‑care operator to a specialist infrastructure buyer and unlock value for Bain’s limited partners.

Sector‑Focused Deal Activity Advaya Capital acquired Comscore Movies in a carve‑out, adding a niche box‑office analytics business to its portfolio and underscoring private equity’s appetite for data‑driven media assets. In the oncology space, six deals were reported by PE firms including AEA Investors and Bridgepoint, reflecting a surge in capital chasing high‑margin healthcare assets despite regulatory headwinds. HSG emerged as frontrunner to buy Blackstone’s 45% stake in Leica Camera, a bid that would give the German investment house a foothold in premium imaging equipment and diversify its industrial exposure.

Large‑Scale Credit Partnerships Apollo and Blackstone syndicated a $36bn debt package to fund Anthropic’s AI build‑out, marking one of the biggest private‑credit transactions of the year and illustrating how legacy lenders are deepening exposure to generative‑AI infrastructure. The financing, structured as a revolving credit facility, will support Anthropic’s model training and cloud‑compute spending, while offering investors a high‑yield, secured exposure to a fast‑growing AI unicorn.

Regional Team Expansions Tikehau and Omni Partners bolstered their European presence by adding senior professionals to their French and German offices, a response to heightened deal flow in the region’s mid‑market segment. Simultaneously, Quad‑C brought Ali Shams on board as managing director, leveraging his technology operating background to sharpen the firm’s portfolio‑company value‑creation playbook.

Operational Discipline & Value Creation Industry analysts warned that operating models, not value‑creation plans, limit performance, emphasizing that disciplined execution across sourcing, integration and exit phases drives superior returns. This view aligns with a recent placement‑agent ranking that highlighted their continued relevance in supporting emerging managers, especially as limited partners demand tighter reporting and alignment on fee structures.

Niche Consumer & Nutrition Investments Axum Capital invested in nutrition brand VitaHustle, providing growth capital to a startup founded by Kevin Hart and Ron Everline that targets health‑conscious consumers with ready‑to‑drink protein blends. The infusion, though undisclosed, is part of a broader trend of private‑equity firms seeking to capture upside in the fast‑growing functional‑beverage market.

ETF Innovation Touching Private‑Equity Strategies JP Morgan Asset Management launched a Managed Futures Plus ETF on Nasdaq, expanding the firm’s active‑ETF suite and offering investors a liquid vehicle to gain exposure to systematic futures strategies, a product class that private‑equity allocators are increasingly using for short‑term cash‑management and diversification.